Attention-deficit/hyperactivity disorder (ADHD) is a common and impairing disorder affecting children, adolescents, and adults. Stimulant class of medications are considered first-line treatment for ADHD, including methylphenidate and amphetamine.
Psychiatry Education Forum Academy’s most recent video discussion posted today will compare the following three long-acting methylphenidate formulations:
- Jornay PM
- Adhansia XR
Here is one of the slides from this presentation, which will explain the reason behind using Jornay PM in the evening time rather than morning time dosing:
This video discussion will compare these medications in the following sections:
- FDA-approved age group.
- Timing of administration.
- How are the onset and duration of action different for each medication, in terms of time to reach the peak concentration?
- Is Adhsnasia XR any different than Concerta?
- Which medications can be opened and sprinkled on food?
- Dosing titration schedule for Jornay PM and Adhansia XR.
- Dose conversion among methylphenidate preparation.
Academy members will have access to the following lecture series:
Comparing Long-Acting Methylphenidate Formulations
INTERESTED IN LEARNING MORE?
JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP
This is a closed membership for medical professionals only.
- 30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice.
- Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
- Coffee Club: contain short discussions with clinical experts in the field of psychiatry.
- Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections.
- Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
- Conference Discounts: Academy members get discounted access at our conferences.
- Goal: is to have all important clinically relevant topics in one place for ease of access.